APA (7th ed.) Citation

Rovers, S., Janssens, A., Raskin, J., Pauwels, P., Meerbeeck, J. P. v., Smits, E., & Marcq, E. (2022). Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma. MDPI AG.

Chicago Style (17th ed.) Citation

Rovers, Sophie, Annelies Janssens, Jo Raskin, Patrick Pauwels, Jan P. van Meerbeeck, Evelien Smits, and Elly Marcq. Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma. MDPI AG, 2022.

MLA (9th ed.) Citation

Rovers, Sophie, et al. Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma. MDPI AG, 2022.